Apr Applied Pharma Research S.a.
Clinical trials sponsored by Apr Applied Pharma Research S.a., explained in plain language.
-
New PKU drink tested for better blood control in kids
Disease control CompletedThis study tested a new protein substitute called PKU GOLIKE against standard amino acid substitutes in 16 children with PKU. The goal was to see if it helps keep blood phenylalanine levels more stable. Children took each product for a week, with a two-week break in between, and …
Phase: NA • Sponsor: APR Applied Pharma Research s.a. • Aim: Disease control
Last updated May 26, 2026 12:12 UTC
-
New liquid version of PKU drug tested for equivalence
Knowledge-focused CompletedThis study tested whether a new liquid form of the drug sapropterin works the same as the current powder form in healthy adults. 42 participants received a single dose of each version under fed conditions, and researchers measured drug levels in the blood. The goal was to confirm…
Phase: PHASE1 • Sponsor: APR Applied Pharma Research s.a. • Aim: Knowledge-focused
Last updated May 26, 2026 10:35 UTC